Christopher Desmond to Drug Therapy, Combination
This is a "connection" page, showing publications Christopher Desmond has written about Drug Therapy, Combination.
Connection Strength
0,122
-
Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting. J Viral Hepat. 2006 May; 13(5):311-5.
Score: 0,060
-
Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohort. Intern Med J. 2019 06; 49(6):753-760.
Score: 0,037
-
Is Option B+ the best choice? Lancet. 2013 Jan 26; 381(9863):269-71.
Score: 0,024